title: Cyclooxygenase-2 (COX-2) in multiple myeloma: prognostic factor or therapeutic target?
authors.forename: Roger G
authors.initials: RG
authors.lastname: Owen
authors.forename: Im
authors.initials: I
authors.lastname: Fan
authors.forename: Sheila J M
authors.initials: SJ
authors.lastname: O'connor
authors.forename: Rebecca A
authors.initials: RA
authors.lastname: Rollett
authors.forename: J
authors.initials: J
authors.lastname: Anthony Child
authors.forename: Faith E
authors.initials: FE
authors.lastname: Davies
authors.forename: Andy C
authors.initials: AC
authors.lastname: Rawstron
mesh_terms: D000911:Antibodies, Monoclonal; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D051546:Cyclooxygenase 2 / Q000097:blood*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008565:Membrane Proteins / Q000097:blood*; D009101:Multiple Myeloma / Q000097:blood*; D010950:Plasma Cells / Q000201:enzymology*
chemical_list: D000911:Antibodies, Monoclonal; D015415:Biomarkers; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human